- Home
- Publications
- Publication Search
- Publication Details
Title
Viral Vector-Mediated Antisense Therapy for Genetic Diseases
Authors
Keywords
-
Journal
Genes
Volume 8, Issue 2, Pages 51
Publisher
MDPI AG
Online
2017-01-26
DOI
10.3390/genes8020051
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Longitudinal effect of eteplirsen versus historical control on ambulation in Duchenne muscular dystrophy
- (2016) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Somatic Therapy of a Mouse SMA Model with a U7 snRNA Gene Correcting SMN2 Splicing
- (2016) Philipp Odermatt et al. MOLECULAR THERAPY
- Big win possible for Ionis/Biogen antisense drug in muscular atrophy
- (2016) Ken Garber NATURE BIOTECHNOLOGY
- Results from a phase 1 study of nusinersen (ISIS-SMNRx) in children with spinal muscular atrophy
- (2016) Claudia A. Chiriboga et al. NEUROLOGY
- Systemic peptide-mediated oligonucleotide therapy improves long-term survival in spinal muscular atrophy
- (2016) Suzan M. Hammond et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Long-Term Efficacy, Safety, and Pharmacokinetics of Drisapersen in Duchenne Muscular Dystrophy: Results from an Open-Label Extension Study
- (2016) Nathalie M. Goemans et al. PLoS One
- Improvement of SMN2 Pre-mRNA Processing Mediated by Exon-Specific U1 Small Nuclear RNA
- (2015) Andrea Dal Mas et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Immunological and hematological toxicities challenging clinical translation of nucleic acid-based therapeutics
- (2015) Marina A Dobrovolskaia et al. EXPERT OPINION ON BIOLOGICAL THERAPY
- Motor neuron cell-nonautonomous rescue of spinal muscular atrophy phenotypes in mild and severe transgenic mouse models
- (2015) Yimin Hua et al. GENES & DEVELOPMENT
- How much dystrophin is enough: the physiological consequences of different levels of dystrophin in themdxmouse
- (2015) Caroline Godfrey et al. HUMAN MOLECULAR GENETICS
- Functional correction in mouse models of muscular dystrophy using exon-skipping tricyclo-DNA oligomers
- (2015) Aurélie Goyenvalle et al. NATURE MEDICINE
- Short antisense-locked nucleic acids (all-LNAs) correct alternative splicing abnormalities in myotonic dystrophy
- (2015) Agnieszka Wojtkowiak-Szlachcic et al. NUCLEIC ACIDS RESEARCH
- Systemic AAVrh10 provides higher transgene expression than AAV9 in the brain and the spinal cord of neonatal mice
- (2015) Yannick Tanguy et al. Frontiers in Molecular Neuroscience
- Simple downstream process based on detergent treatment improves yield and in vivo transduction efficacy of adeno-associated virus vectors
- (2015) Gabriella Dias Florencio et al. Molecular Therapy-Methods & Clinical Development
- Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy
- (2014) Balaji Balakrishnan et al. CURRENT GENE THERAPY
- Safety and efficacy of drisapersen for the treatment of Duchenne muscular dystrophy (DEMAND II): an exploratory, randomised, placebo-controlled phase 2 study
- (2014) Thomas Voit et al. LANCET NEUROLOGY
- Forelimb Treatment in a Large Cohort of Dystrophic Dogs Supports Delivery of a Recombinant AAV for Exon Skipping in Duchenne Patients
- (2014) Caroline Le Guiner et al. MOLECULAR THERAPY
- Eteplirsen for the treatment of Duchenne muscular dystrophy
- (2013) Jerry R. Mendell et al. ANNALS OF NEUROLOGY
- Exon Skipping as a Therapeutic Strategy Applied to an RYR1 Mutation with Pseudo-Exon Inclusion Causing a Severe Core Myopathy
- (2013) John Rendu et al. HUMAN GENE THERAPY
- A Novel Morpholino Oligomer Targeting ISS-N1 Improves Rescue of Severe Spinal Muscular Atrophy Transgenic Mice
- (2013) Haiyan Zhou et al. HUMAN GENE THERAPY
- Intramuscular scAAV9-SMN Injection Mediates Widespread Gene Delivery to the Spinal Cord and Decreases Disease Severity in SMA Mice
- (2013) Sofia Benkhelifa-Ziyyat et al. MOLECULAR THERAPY
- AAV Genome Loss From Dystrophic Mouse Muscles During AAV-U7 snRNA-mediated Exon-skipping Therapy
- (2013) Maëva Le Hir et al. MOLECULAR THERAPY
- Pharmacokinetics and safety of single doses of drisapersen in non-ambulant subjects with Duchenne muscular dystrophy: Results of a double-blind randomized clinical trial
- (2013) Kevin M. Flanigan et al. NEUROMUSCULAR DISORDERS
- Intracellular transport of recombinant adeno-associated virus vectors
- (2012) M Nonnenmacher et al. GENE THERAPY
- Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPLS447X) gene therapy for lipoprotein lipase deficiency: an open-label trial
- (2012) D Gaudet et al. GENE THERAPY
- An exon-specific U1 small nuclear RNA (snRNA) strategy to correct splicing defects
- (2012) Eugenio Fernandez Alanis et al. HUMAN MOLECULAR GENETICS
- Rescue of severely affected dystrophin/utrophin-deficient mice through scAAV-U7snRNA-mediated exon skipping
- (2012) Aurélie Goyenvalle et al. HUMAN MOLECULAR GENETICS
- Virus-mediated gene delivery for human gene therapy
- (2012) Mauro Giacca et al. JOURNAL OF CONTROLLED RELEASE
- Muscle Function Recovery in Golden Retriever Muscular Dystrophy After AAV1-U7 Exon Skipping
- (2012) Adeline Vulin et al. MOLECULAR THERAPY
- Engineering Multiple U7snRNA Constructs to Induce Single and Multiexon-skipping for Duchenne Muscular Dystrophy
- (2012) Aurélie Goyenvalle et al. MOLECULAR THERAPY
- Targeting nuclear RNA for in vivo correction of myotonic dystrophy
- (2012) Thurman M. Wheeler et al. NATURE
- Global gene transfer into the CNS across the BBB after neonatal systemic delivery of single-stranded AAV vectors
- (2011) Noriko Miyake et al. BRAIN RESEARCH
- Optimization of Lentiviral Vectors Generation for Biomedical and Clinical Research Purposes: Contemporary Trends in Technology Development and Applications
- (2011) Pankaj Kumar et al. CURRENT GENE THERAPY
- A single administration of morpholino antisense oligomer rescues spinal muscular atrophy in mouse
- (2011) Paul N. Porensky et al. HUMAN MOLECULAR GENETICS
- Exon skipping and dystrophin restoration in patients with Duchenne muscular dystrophy after systemic phosphorodiamidate morpholino oligomer treatment: an open-label, phase 2, dose-escalation study
- (2011) Sebahattin Cirak et al. LANCET
- Preclinical Differences of Intravascular AAV9 Delivery to Neurons and Glia: A Comparative Study of Adult Mice and Nonhuman Primates
- (2011) Steven J Gray et al. MOLECULAR THERAPY
- Systemic Gene Delivery in Large Species for Targeting Spinal Cord, Brain, and Peripheral Tissues for Pediatric Disorders
- (2011) Adam K Bevan et al. MOLECULAR THERAPY
- Restoration of the Dystrophin-associated Glycoprotein Complex After Exon Skipping Therapy in Duchenne Muscular Dystrophy
- (2011) Sebahattin Cirak et al. MOLECULAR THERAPY
- Bifunctional RNAs Targeting the Intronic Splicing Silencer N1 Increase SMN Levels and Reduce Disease Severity in an Animal Model of Spinal Muscular Atrophy
- (2011) Erkan Y Osman et al. MOLECULAR THERAPY
- Long-term Restoration of Cardiac Dystrophin Expression in Golden Retriever Muscular Dystrophy Following rAAV6-mediated Exon Skipping
- (2011) Lawrence T Bish et al. MOLECULAR THERAPY
- Peripheral SMN restoration is essential for long-term rescue of a severe spinal muscular atrophy mouse model
- (2011) Yimin Hua et al. NATURE
- Systemic Administration of PRO051 in Duchenne's Muscular Dystrophy
- (2011) Nathalie M. Goemans et al. NEW ENGLAND JOURNAL OF MEDICINE
- Design principles for bifunctional targeted oligonucleotide enhancers of splicing
- (2011) N. Owen et al. NUCLEIC ACIDS RESEARCH
- Antisense Oligonucleotides Delivered to the Mouse CNS Ameliorate Symptoms of Severe Spinal Muscular Atrophy
- (2011) M. A. Passini et al. Science Translational Medicine
- Antisense correction of SMN2 splicing in the CNS rescues necrosis in a type III SMA mouse model
- (2010) Y. Hua et al. GENES & DEVELOPMENT
- Exon Skipping and Duchenne Muscular Dystrophy Therapy: Selection of the Most Active U1 snRNA Antisense Able to Induce Dystrophin Exon 51 Skipping
- (2010) Tania Incitti et al. MOLECULAR THERAPY
- Replication-competent Lentivirus Analysis of Clinical Grade Vector Products
- (2010) Kenneth Cornetta et al. MOLECULAR THERAPY
- Physiological Characterization of Muscle Strength With Variable Levels of Dystrophin Restoration in mdx Mice Following Local Antisense Therapy
- (2010) Paul S Sharp et al. MOLECULAR THERAPY
- Selective silencing of mutated mRNAs in DM1 by using modified hU7-snRNAs
- (2010) Virginie François et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Ultrastructural changes in diaphragm neuromuscular junctions in a severe mouse model for Spinal Muscular Atrophy and their prevention by bifunctional U7 snRNA correcting SMN2 splicing
- (2010) Tilman Voigt et al. NEUROMUSCULAR DISORDERS
- The Spliceosome: Design Principles of a Dynamic RNP Machine
- (2009) Markus C. Wahl et al. CELL
- DHPR α1S subunit controls skeletal muscle mass and morphogenesis
- (2009) France Piétri-Rouxel et al. EMBO JOURNAL
- Intron 7 conserved sequence elements regulate the splicing of the SMN genes
- (2009) Jordan T. Gladman et al. HUMAN GENETICS
- Delivery of bifunctional RNAs that target an intronic repressor and increase SMN levels in an animal model of spinal muscular atrophy
- (2009) T. D. Baughan et al. HUMAN MOLECULAR GENETICS
- Efficient bypass of mutations in dysferlin deficient patient cells by antisense-induced exon skipping
- (2009) Nicolas Wein et al. HUMAN MUTATION
- Intravenous Administration of Self-complementary AAV9 Enables Transgene Delivery to Adult Motor Neurons
- (2009) Sandra Duque et al. MOLECULAR THERAPY
- Enhanced Exon-skipping Induced by U7 snRNA Carrying a Splicing Silencer Sequence: Promising Tool for DMD Therapy
- (2009) Aurélie Goyenvalle et al. MOLECULAR THERAPY
- Restoration of Full-Length SMN Promoted by Adenoviral Vectors Expressing RNA Antisense Oligonucleotides Embedded in U7 snRNAs
- (2009) Till Geib et al. PLoS One
- Triplet-repeat oligonucleotide-mediated reversal of RNA toxicity in myotonic dystrophy
- (2009) S. A. M. Mulders et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Reversal of RNA Dominance by Displacement of Protein Sequestered on Triplet Repeat RNA
- (2009) T. M. Wheeler et al. SCIENCE
- Antisense Masking of an hnRNP A1/A2 Intronic Splicing Silencer Corrects SMN2 Splicing in Transgenic Mice
- (2008) Yimin Hua et al. AMERICAN JOURNAL OF HUMAN GENETICS
- Long-Term Benefit of Adeno-Associated Virus/Antisense-Mediated Exon Skipping in Dystrophic Mice
- (2008) Michela Alessandra Denti et al. HUMAN GENE THERAPY
- A Negatively Acting Bifunctional RNA Increases Survival Motor Neuron Both In Vitro and In Vivo
- (2008) Alexa Dickson et al. HUMAN GENE THERAPY
- Rescue of a severe mouse model for spinal muscular atrophy by U7 snRNA-mediated splicing modulation
- (2008) Kathrin Meyer et al. HUMAN MOLECULAR GENETICS
- Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes
- (2008) Kevin D Foust et al. NATURE BIOTECHNOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More